Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

North America Glioma Market Size

The global glioma market was valued at USD 1 billion in 2023, with North America holding a significant market share. The market is driven by the rising innovation in glioma therapies and increased regulatory approvals of advanced medications. It is expected to grow at a CAGR of 3.22% during the forecast period of 2024-2032, with the values likely to attain USD 1.3 billion by 2032.

 

North America Glioma Market Outlook

  • The rising burden of glioma along with the growing aging population more susceptible to developing this brain tumor is expected to augment the market demand.
  • One of the major North America glioma market trends is the surge in approvals of advanced glioma therapies and diagnostic methods by the health regulatory bodies.
  • Increased innovation in treatment modalities and the growing emphasis on personalized therapeutic approaches are projected to elevate the market value.

 

North America Glioma Market Report Snapshots

North America Glioma Market Size

North America Glioma Market Analysis

North America Glioma Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The North America glioma market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 3.22% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1.3 billion by 2032.

The rising prevalence of glioma along with the growing aging population is fuelling the demand for the market.

One of the significant trends in the market is the increased approval of advanced glioma therapies. For instance, in February 2024, Servier Pharmaceuticals LLC’s vorasidenib (AG-881) new drug application was accepted and granted priority review by the FDA for the treatment of patients with IDH-mutant diffuse glioma.

Based on the type, the market is segmented into astrocytoma, oligodendroglioma, and glioblastoma.

By diagnosis, the market is divided into angiograms, magnetic resonance imaging (MRI), computerized tomography (CT), and surgical biopsy, among others.

The market breakup by treatment type includes chemotherapy, radiation, and surgery.

The market breakup by route of administration includes oral and parenteral.

The market segmentation by countries includes the United States and Canada.

The key players in the market are Pfizer Inc., Novartis AG, Johnson & Johnson, Merck & Co., Inc., Roche Holding AG, Bristol-Myers Squibb Company, Amgen Inc., AstraZeneca PLC, Eli Lilly and Company, and AbbVie Inc. 

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,399

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 5,299

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 6,299

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear = calculateFutureValue(($getReportDetail['base_value'] > 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>